South Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Country Analysis – by Product (Embolic Agents and Support Devices), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Diseases, Urological & Nephrological Disorders, Gastrointestinal Disorders, and Others), Procedure (Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)), and End User (Hospitals & Clinics, Ambulatory Surgery Centers, and Other End Users)

Code: BMIRE00025506 | Pages: 163 | Industry: Medical Device | Date: Aug 2022
Covid

The South Africa embolotherapy market is expected to reach US$ 65.47 million in 2028 from US$ 42.09 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2022 to 2028.

The South Africa embolotherapy market is segmented on the basis of product, disease indication, procedure, end user, and country. The report offers insights and in-depth analysis of the market, emphasizing various parameters such as market trends and opportunities, market dynamics, and competitive landscape analysis of leading market players across South Africa. It also includes the impact analysis of COVID–19 pandemic across the country.

Market Insights

Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism

Hypertension, smoking, alcoholism, and obesity are associated with developing brain aneurysms. South Africa has the highest prevalence of hypertension; however, the level of awareness and control of the disease is low among communities. According to WHO data, ~27.4% of men and 26.1% of women in South Africa have hypertension, and the prevalence of hypertension was reported to be 60% in 2019. Moreover, obesity is a public health issue in South Africa, and 31% of men and 68% of women in South Africa are obese. In addition, the country is among the world's top five countries with the highest consumption of absolute alcohol per drinker per year. According to WHO, South Africa is affected as 1 in 10 deaths are associated with alcohol use, and approximately half of men and one-fifth of women consume alcohol in South Africa.

Kidney cancer is becoming more common in people of all ages and races, and hypertension, obesity, and smoking are all risk factors for kidney cancer. Obesity is associated with high blood pressure, dyslipidemia, diabetes, and higher fibrinogen levels, which also increase the risk of cardiovascular diseases (CVD). Thus, the increasing prevalence of such diseases fuels the demand for embolotherapy.

Bariatric embolization is a new endovascular technique to cure patients with obesity. Bariatric embolization carries embolic microspheres into the gastric arteries to induce localized ischemia and has modified appetite hormones, leading to reduced weight. Thus, the increasing prevalence of hypertension, smoking, alcoholism, and obesity propels the growth of the South Africa embolotherapy market.

Product-Based Insights

Based on product, the South Africa embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents segment held a larger market share in 2021 and is anticipated to register a higher CAGR in the market during the forecast period. Embolic agents apply mechanical occlusion to block blood flow in one or more blood vessels or abnormal vascular areas. Various embolic agents are placed by using certain ways, such as through catheters into the blood vessels, to inhibit blood flow to a specific area. Embolizing agents such as embolic microsphere restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines that elute and diffuse into the tissue.

Moreover, in interventional radiology, embolization is a common procedure, and the increasing use of embolic agents in various interventional radiology procedures and advancements in such agents, such as calibrated microspheres for bland embolization and drug-eluting microspheres for treating primary or secondary liver disease are the reasons for the growth of this segment. Furthermore, the embolic agents segment is sub-segmented into microspheres, embolic coil, liquid embolic agents, embolic plug systems, detachable balloons, and others.

South Africa Embolotherapy Market, by Product – 2021 & 2028

South Africa Embolotherapy Market, by Product – 2021 & 2028

Get more information on this report :

Disease Indication-Based Insights

Based on disease indication, the South Africa embolotherapy market is segmented into cancer, peripheral vascular disease, neurological diseases, urological & nephrological disorders, gastrointestinal disorders, and others. The cancer segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Embolization is used to treat cancers such as neuroendocrine tumors, renal cell carcinoma, and hepatocellular carcinoma. The goal of embolization in cancer treatment is to remove the tumor, which cannot be removed surgically due to its deep location within the body. Embolization can also stop fatal bleeding caused by a tumor, and the choice of embolization agents depends on the indication. Some common embolization agents used for treating tumors are metal coils, PVA particles, and soluble gelatin sponge. Thus, embolotherapy is rapidly becoming a preferred treatment for cancer as it cuts the tumor from the blood supply, essentially starving it of nutrients. The procedure has a high success rate and less post-operative complication rate.

Moreover, rising cancer and hepatocellular cancer incidences are the key factors fueling the demand for embolotherapy devices for cancer disease indication during the forecast period. Cancer is the fifth leading cause of death in Africa. The prevalence of cancer has been rising continuously over the last few decades due to a combination of environmental and lifestyle factors and variations in screening and diagnosis. According to Ascopost, an estimated 110,000 new cancer cases were diagnosed in South Africa in 2020, with more than 56,000 cancer-related deaths.

Procedure-Based Insights

Based on procedure, the South Africa embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period. Transcatheter arterial embolization (TAE) is a procedure in which the blood supply to a tumor or an abnormal tissue area is blocked. During TAE procedure, a small incision is made in the inner thigh, and a catheter is inserted and guided into an artery near the tumor. Once the catheter is in place, small particles made of sponges or beads are injected into the artery, blocking the artery and stopping the blood flow to the tumor. Transarterial embolization is used to treat some types of liver cancer, kidney cancer, neuroendocrine tumors, uterine fibroids, aneurysms, and other conditions. Moreover, TAE is effective and well-tolerated in patients with ruptured hepatocellular carcinoma (HCC). This procedure is expected to be the fastest-growing category during the forecast period owing to the rising preference for minimally invasive procedures by the elderly and the growing prevalence of chronic diseases.

End User-Based Insights

Based on end user, the South Africa embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

Strategic Insights

Companies commonly adopt inorganic strategies such as mergers and acquisitions to meet changing customer demand and maintain their brand name worldwide. Players operating in the South Africa embolotherapy market also adopt organic strategies such as product launch and expansion to outstretch their footprint and product portfolio worldwide.

In March 2022, Guerbet expanded its portfolio with microcatheters and guidewires for interventional imaging and embolization.

In July 2021, Terumo introduced a new AZUR Vascular Plug and PG Pro Peripheral Microcatheter Embolization System.

Company Profiles

  • Abbott Laboratories           
  • Boston Scientific Corporation         
  • Cook Medical LLC                
  • Johnson & Johnson Consumer Inc                
  • Medtronic              
  • Acandis GmbH     
  • Terumo Corporation          
  • Balt USA LLC          
  • Stryker Corporation           
  • Guerbet LLC.

1.     INTRODUCTION

            1.1.       SCOPE OF THE STUDY

            1.2.       THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

            1.3.       MARKET SEGMENTATION

                         1.3.1   Embolotherapy Market - By Product

                         1.3.2   Embolotherapy Market - By Disease Indication

                         1.3.3   Embolotherapy Market - By Procedure

                         1.3.4   Embolotherapy Market - By End User

2.        KEY TAKEAWAYS

3.        RESEARCH METHODOLOGY

4.        EMBOLOTHERAPY MARKET LANDSCAPE

            4.1.       OVERVIEW

            4.2.       PEST ANALYSIS

                         4.2.1        South Africa - Pest Analysis

            4.3.       EXPERT OPINIONS

5.        EMBOLOTHERAPY MARKET - KEY MARKET DYNAMICS

            5.1.       KEY MARKET DRIVERS

            5.2.       KEY MARKET RESTRAINTS

            5.3.       KEY MARKET OPPORTUNITIES

            5.4.       FUTURE TRENDS

            5.5.       IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6.        EMBOLOTHERAPY MARKET - SOUTH AFRICA MARKET ANALYSIS

            6.1.       EMBOLOTHERAPY - SOUTH AFRICA MARKET OVERVIEW

            6.2.       EMBOLOTHERAPY - SOUTH AFRICA MARKET AND FORECAST TO 2028

            6.3.       MARKET POSITIONING

7.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT

            7.1.       OVERVIEW

            7.2.       PRODUCT MARKET FORECASTS AND ANALYSIS

            7.3.       EMBOLIC AGENTS

                          7.3.1.         Overview

                          7.3.2.         Embolic Agents Market Forecast and Analysis

                          7.3.3.         Microspheres Market

                                            7.3.3.1.        Overview

                                            7.3.3.2.        Microspheres Market Forecast and Analysis

                          7.3.4.          Embolic Coils Market

                                            7.3.4.1.        Overview

                                            7.3.4.2.         Embolic Coils Market Forecast and Analysis

                          7.3.5.          Liquid Embolic Agents Market

                                            7.3.5.1.        Overview

                                            7.3.5.2.         Liquid Embolic Agents Market Forecast and Analysis

                          7.3.6.          Embolic Plug Systems Market

                                            7.3.6.1.        Overview

                                            7.3.6.2.         Embolic Plug Systems Market Forecast and Analysis

                          7.3.7.          Detachable Balloons Market

                                            7.3.7.1.        Overview

                                            7.3.7.2.         Detachable Balloons Market Forecast and Analysis

            7.4.       SUPPORT DEVICES

                          7.4.1.         Overview

                          7.4.2.         Support Devices Market Forecast and Analysis

                          7.4.3.         Microcatheters Market

                                            7.4.3.1.        Overview

                                            7.4.3.2.        Microcatheters Market Forecast and Analysis

                          7.4.4.          Guidewires Market

                                            7.4.4.1.        Overview

                                            7.4.4.2.         Guidewires Market Forecast and Analysis

8.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – DISEASE INDICATION

            8.1.       OVERVIEW

            8.2.       DISEASE INDICATION MARKET FORECASTS AND ANALYSIS

            8.3.       CANCER

                          8.3.1.         Overview

                          8.3.2.         Cancer Market Forecast and Analysis

                          8.3.3.         Liver Cancer Market

                                            8.3.3.1.        Overview

                                            8.3.3.2.        Liver Cancer Market Forecast and Analysis

                          8.3.4.          Kidney Cancer Market

                                            8.3.4.1.        Overview

                                            8.3.4.2.         Kidney Cancer Market Forecast and Analysis

                          8.3.5.          Other Cancers Market

                                            8.3.5.1.        Overview

                                            8.3.5.2.         Other Cancers Market Forecast and Analysis

            8.4.       PERIPHERAL VASCULAR DISEASE

                          8.4.1.         Overview

                          8.4.2.         Peripheral Vascular Disease Market Forecast and Analysis

            8.5.       NEUROLOGICAL DISEASES

                          8.5.1.         Overview

                          8.5.2.         Neurological Diseases Market Forecast and Analysis

            8.6.       UROLOGICAL AND NEPHROLOGICAL DISORDERS

                          8.6.1.         Overview

                          8.6.2.         Urological and Nephrological Disorders Market Forecast and Analysis

            8.7.       GASTROINTESTINAL DISORDERS

                          8.7.1.         Overview

                          8.7.2.         Gastrointestinal Disorders Market Forecast and Analysis

9.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – PROCEDURE

            9.1.       OVERVIEW

            9.2.       PROCEDURE MARKET FORECASTS AND ANALYSIS

            9.3.       TRANSCATHETER ARTERIAL EMBOLIZATION (TAE)

                          9.3.1.         Overview

                          9.3.2.         Transcatheter Arterial Embolization (TAE) Market Forecast and Analysis

            9.4.       TRANSCATHETER ARTERIAL RADIOEMBOLIZATION (TARE)/SELECTIVE INTERNAL RADIATION THERAPY (SIRT)

                          9.4.1.         Overview

                          9.4.2.         Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT) Market Forecast and Analysis

            9.5.       TRANSARTERIAL CHEMOEMBOLIZATION (TACE)

                          9.5.1.         Overview

                          9.5.2.         Transarterial Chemoembolization (TACE) Market Forecast and Analysis

10.        EMBOLOTHERAPY MARKET - REVENUE AND FORECASTS TO 2028 – END USER

               10.1.       OVERVIEW

               10.2.       END USER MARKET FORECASTS AND ANALYSIS

               10.3.       HOSPITALS AND CLINICS

                             10.3.1.         Overview

                             10.3.2.         Hospitals and Clinics Market Forecast and Analysis

               10.4.       AMBULATORY SURGERY CENTERS

                             10.4.1.         Overview

                             10.4.2.         Ambulatory Surgery Centers Market Forecast and Analysis

               10.5.       OTHER END USERS

                             10.5.1.         Overview

                             10.5.2.         Other End Users Market Forecast and Analysis

11.        IMPACT OF COVID-19 PANDEMIC ON EMBOLOTHERAPY MARKET

               11.1        SOUTH AFRICA

12.        INDUSTRY LANDSCAPE

               12.1.       MERGERS AND ACQUISITIONS

               12.2.       AGREEMENTS, COLLABORATIONS AND JOIN VENTURES

               12.3.       NEW PRODUCT LAUNCHES

               12.4.       EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

13.        EMBOLOTHERAPY MARKET, KEY COMPANY PROFILES

               13.1.     ABBOTT LABORATORIES

                              13.1.1.      Key Facts

                              13.1.2.      Business Description

                              13.1.3.      Products and Services

                              13.1.4.      Financial Overview

                              13.1.5.      SWOT Analysis

                              13.1.6.      Key Developments

               13.2.     ACANDIS GMBH

                              13.2.1.      Key Facts

                              13.2.2.      Business Description

                              13.2.3.      Products and Services

                              13.2.4.      Financial Overview

                              13.2.5.      SWOT Analysis

                              13.2.6.      Key Developments

               13.3.     BOSTON SCIENTIFIC CORPORATION

                              13.3.1.      Key Facts

                              13.3.2.      Business Description

                              13.3.3.      Products and Services

                              13.3.4.      Financial Overview

                              13.3.5.      SWOT Analysis

                              13.3.6.      Key Developments

               13.4.     STRYKER CORPORATION

                              13.4.1.      Key Facts

                              13.4.2.      Business Description

                              13.4.3.      Products and Services

                              13.4.4.      Financial Overview

                              13.4.5.      SWOT Analysis

                              13.4.6.      Key Developments

               13.5.     JOHNSON AND JOHNSON

                              13.5.1.      Key Facts

                              13.5.2.      Business Description

                              13.5.3.      Products and Services

                              13.5.4.      Financial Overview

                              13.5.5.      SWOT Analysis

                              13.5.6.      Key Developments

               13.6.     MEDTRONIC

                              13.6.1.      Key Facts

                              13.6.2.      Business Description

                              13.6.3.      Products and Services

                              13.6.4.      Financial Overview

                              13.6.5.      SWOT Analysis

                              13.6.6.      Key Developments

               13.7.     COOK MEDICAL

                              13.7.1.      Key Facts

                              13.7.2.      Business Description

                              13.7.3.      Products and Services

                              13.7.4.      Financial Overview

                              13.7.5.      SWOT Analysis

                              13.7.6.      Key Developments

               13.8.     Guerbet LLC.

                              13.8.1.      Key Facts

                              13.8.2.      Business Description

                              13.8.3.      Products and Services

                              13.8.4.      Financial Overview

                              13.8.5.      SWOT Analysis

                              13.8.6.      Key Developments

               13.9.     BALT EXTRUSION

                              13.9.1.      Key Facts

                              13.9.2.      Business Description

                              13.9.3.      Products and Services

                              13.9.4.      Financial Overview

                              13.9.5.      SWOT Analysis

                              13.9.6.      Key Developments

               13.10.     TERUMO CORPORATION

                              13.10.1.      Key Facts

                              13.10.2.      Business Description

                              13.10.3.      Products and Services

                              13.10.4.      Financial Overview

                              13.10.5.      SWOT Analysis

                              13.10.6.      Key Developments

14.        APPENDIX

               14.1.       ABOUT THE INSIGHT PARTNERS

               14.2.       GLOSSARY OF TERMS

 

LIST OF TABLES

Table 1.South Africa. Embolotherapy Market, by Product – Revenue and Forecast to 2028 (US$ Million)

Table 2.South Africa. Embolotherapy Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3.South Africa. Embolotherapy Market, by Procedure – Revenue and Forecast to 2028 (US$ Million)

Table 4.South Africa. Embolotherapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 5.Organic Developments Done By Companies

Table 6.Inorganic Developments Done by Companies

Table 7.Glossary of Terms, Embolotherapy Market

 

  1. Abbott Laboratories           
  2. Boston Scientific Corporation         
  3. Cook Medical LLC                
  4. Johnson & Johnson Consumer Inc                
  5. Medtronic              
  6. Acandis GmbH     
  7. Terumo Corporation          
  8. Balt USA LLC          
  9. Stryker Corporation           
  10. Guerbet LLC.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Related Tags South Africa Embolotherapy Market South Africa Embolotherapy Market Research South Africa Embolotherapy Market Insight South Africa Embolotherapy Market Trends South Africa Embolotherapy Market Forecast South Africa Embolotherapy Market Share South Africa Embolotherapy Market 2028 South Africa Embolotherapy Market Growth South Africa Embolotherapy Industry Sector South Africa Embolotherapy PDF Report South Africa Embolotherapy Analysis South Africa Embolotherapy Research Competitive Analysis Business Market Insights

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000